APA (7th ed.) Citation

B, L., J, K., B, G., R, C., LS, F., T, H., . . . DM, T. (2022). Persistent Immune Activation in Human Immunodeficiency Virus-Infected Pregnant Women Starting Combination Antiretroviral Therapy After Conception. The Journal of infectious diseases, 225(7), 1162. https://doi.org/10.1093/infdis/jiab095

Chicago Style (17th ed.) Citation

B, Lohman-Payne, et al. "Persistent Immune Activation in Human Immunodeficiency Virus-Infected Pregnant Women Starting Combination Antiretroviral Therapy After Conception." The Journal of Infectious Diseases 225, no. 7 (2022): 1162. https://doi.org/10.1093/infdis/jiab095.

MLA (9th ed.) Citation

B, Lohman-Payne, et al. "Persistent Immune Activation in Human Immunodeficiency Virus-Infected Pregnant Women Starting Combination Antiretroviral Therapy After Conception." The Journal of Infectious Diseases, vol. 225, no. 7, 2022, p. 1162, https://doi.org/10.1093/infdis/jiab095.